GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Other Assets for Banks

BioPharma Credit (LSE:BPCR) Other Assets for Banks : $1,194.0 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Other Assets for Banks?

BioPharma Credit's quarterly other assets (bank) declined from Dec. 2023 ($1,221.7 Mil) to Jun. 2024 ($1,194.5 Mil) and declined from Jun. 2024 ($1,194.5 Mil) to Dec. 2024 ($1,194.0 Mil).

BioPharma Credit's annual other assets (bank) declined from Dec. 2022 ($1,243.5 Mil) to Dec. 2023 ($1,221.7 Mil) and declined from Dec. 2023 ($1,221.7 Mil) to Dec. 2024 ($1,194.0 Mil).


BioPharma Credit Other Assets for Banks Historical Data

The historical data trend for BioPharma Credit's Other Assets for Banks can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Other Assets for Banks Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Assets for Banks
Get a 7-Day Free Trial 1,195.04 1,275.91 1,243.49 1,221.68 1,194.00

BioPharma Credit Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Assets for Banks Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,243.49 - 1,221.68 1,194.47 1,194.00

BioPharma Credit Other Assets for Banks Calculation

Banks frequently group a variety of accounts as other assets on their balance sheets. Banks must report several of these accounts, such as investment in unconsolidated subsidiaries, customer liability on outstanding acceptances, and intangible assets as separate line items on Call Reports.


BioPharma Credit Business Description

Traded in Other Exchanges
N/A
Address
29 Wellington Street, Central Square, Leeds, GBR, LS1 4DL
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines